Linked from

The 15 pages that link to Allopurinol, each with the reason it gives.

• GoutRelated: Long-term urate reduction with allopurinol helps prevent recurrent flares and crystal deposits.

• PurineRelated: It treats consequences of purine breakdown by blocking a key catabolic enzyme.

• Uric acidRelated: It reduces urate formation in chronic gout and tumor lysis prevention.

• Purine metabolismRelated: It treats gout by reducing the terminal products of purine catabolism.

• HyperuricemiaRelated: It is commonly used for long-term urate lowering in gout.

• Tumor lysis syndromeRelated: It helps prevent new uric acid formation in patients at risk, but does not remove existing uric acid.

• Stevens–Johnson syndromeRelated: It is a well-established cause of severe cutaneous reactions, including this syndrome.

• Xanthine oxidaseRelated: It is a widely used treatment that blocks the enzyme’s catalytic activity.

• FebuxostatCompared with: Like febuxostat, it inhibits xanthine oxidase, but has a different chemical structure and dosing profile.

• ColchicineCompared with: Unlike colchicine, it prevents gout by lowering urate rather than calming an acute inflammatory attack.

• XanthineRelated: It blocks the enzyme that converts xanthine into uric acid.

• HypoxanthineRelated: It limits the conversion of hypoxanthine into uric acid.

• Lesch–Nyhan syndromeRelated: It can reduce uric acid complications, but does not correct the neurological symptoms.

• Gertrude B. ElionBroader topic: Elion’s team developed it to treat gout and reduce uric acid production.

• MercaptopurineCompared with: It alters mercaptopurine breakdown and can dangerously increase exposure unless the mercaptopurine dose is reduced.